Literature DB >> 10753659

DNA fragmentation occurs in skeletal muscle during tumor growth: A link with cancer cachexia?

M van Royen1, N Carbó, S Busquets, B Alvarez, L S Quinn, F J López-Soriano, J M Argilés.   

Abstract

In two different experimental models of cancer cachexia, the rat Yoshida AH-130 ascites hepatoma and the mouse Lewis lung carcinoma, the implantation of the tumor caused a loss of body weight which was associated with a reduction in the weight of different skeletal muscles, as well as with their protein content. The decrease in protein content was accompanied by a reduction in DNA content. Interestingly, the protein/DNA ratio was unchanged in the skeletal muscle of the tumor-bearing animals as compared with the non-tumor-bearing controls. Analysis of DNA fragmentation in skeletal muscle clearly showed enhanced laddering in the skeletal muscle of tumor-bearing animals, suggesting an apoptotic phenomenon. Interestingly, the degree of laddering (total DNA fragmented) increased with tumor burden. These results suggest that DNA fragmentation may be a primary event in cancer-associated cachexia. Copyright 2000 Academic Press.

Entities:  

Mesh:

Year:  2000        PMID: 10753659     DOI: 10.1006/bbrc.2000.2462

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

Review 1.  The "parallel pathway": a novel nutritional and metabolic approach to cancer patients.

Authors:  Maurizio Muscaritoli; Alessio Molfino; Gianfranco Gioia; Alessandro Laviano; Filippo Rossi Fanelli
Journal:  Intern Emerg Med       Date:  2010-07-02       Impact factor: 3.397

2.  Distinct muscle apoptotic pathways are activated in muscles with different fiber types in a rat model of critical illness myopathy.

Authors:  Benjamin T Barnes; Amy L Confides; Mark M Rich; Esther E Dupont-Versteegden
Journal:  J Muscle Res Cell Motil       Date:  2015-03-05       Impact factor: 2.698

3.  Formoterol and cancer muscle wasting in rats: Effects on muscle force and total physical activity.

Authors:  Sílvia Busquets; Míriam Toledo; Sònia Sirisi; Marcel Orpí; Roberto Serpe; Joana Coutinho; Raquel Martínez; Josep M Argilés; Francisco J López-Soriano
Journal:  Exp Ther Med       Date:  2011-04-28       Impact factor: 2.447

Review 4.  New drugs for the anorexia-cachexia syndrome.

Authors:  Mellar P Davis
Journal:  Curr Oncol Rep       Date:  2002-05       Impact factor: 5.075

Review 5.  Cardiac Complications: The Understudied Aspect of Cancer Cachexia.

Authors:  Vivek Bora; Bhoomika Patel
Journal:  Cardiovasc Toxicol       Date:  2022-02-16       Impact factor: 3.231

6.  Vascular endothelial growth factor-A and changes in a tumor-bearing mouse model with Lewis lung cancer.

Authors:  Meng-Shu Tsai; Cheng-Chi Chang; Min-Liang Kuo; Ying-Tai Wu
Journal:  Oncol Lett       Date:  2011-08-09       Impact factor: 2.967

7.  Formoterol treatment downregulates the myostatin system in skeletal muscle of cachectic tumour-bearing rats.

Authors:  Sílvia Busquets; Míriam Toledo; Enrica Marmonti; Marcel Orpí; Eva Capdevila; Angelica Betancourt; Francisco J López-Soriano; Josep M Argilés
Journal:  Oncol Lett       Date:  2011-10-13       Impact factor: 2.967

Review 8.  Mechanisms underlying the anti-wasting effect of L-carnitine supplementation under pathologic conditions: evidence from experimental and clinical studies.

Authors:  Robert Ringseis; Janine Keller; Klaus Eder
Journal:  Eur J Nutr       Date:  2013-03-19       Impact factor: 5.614

9.  Cachexia in the non-obese diabetic mouse is associated with CD4+ T-cell lymphopenia.

Authors:  Chunfang Zhao; Zhuanzhi Wang; Michael W Robertson; Joanna D Davies
Journal:  Immunology       Date:  2008-04-04       Impact factor: 7.397

10.  Cancer cachexia alters intracellular surfactant metabolism but not total alveolar surface area.

Authors:  Tilman Graulich; Suman Kumar Das; Gabriela Krasteva; Clemens Ruppert; Lars Wessels; Gerald Hoefler; Christian Mühlfeld
Journal:  Histochem Cell Biol       Date:  2012-07-19       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.